3,051,100,000 United States dollar
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2021-12-31
- Valid until
- still holds
- Published
- 2022-02-09
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
Sources
Cite this claim
Plain text
AsOf. "Vertex Pharmaceuticals research and development: 3,051,100,000 United States dollar", as of 2021-12-31. Claim clm_A31B2D7AAD7A, https://asof.is/claim/clm_A31B2D7AAD7A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532022000007/0000875320-22-000007-index.htm.
APA
AsOf. (2021). Vertex Pharmaceuticals research and development: 3,051,100,000 United States dollar (as of 2021-12-31) [Record clm_A31B2D7AAD7A]. Retrieved November 9, 2026, from https://asof.is/claim/clm_A31B2D7AAD7A (source: https://www.sec.gov/Archives/edgar/data/875320/000087532022000007/0000875320-22-000007-index.htm)
BibTeX
@misc{asof_clm_A31B2D7AAD7A,
author = {AsOf},
title = {Vertex Pharmaceuticals research and development: 3,051,100,000 United States dollar},
year = {2021},
howpublished = {\url{https://asof.is/claim/clm_A31B2D7AAD7A}},
note = {Claim clm\_A31B2D7AAD7A, as of 2021-12-31; source: https://www.sec.gov/Archives/edgar/data/875320/000087532022000007/0000875320-22-000007-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_A31B2D7AAD7A.md/v1/claims/clm_A31B2D7AAD7Asubmit a correction